Managing bone and bone marrow involvement in neuroblastoma with anti-GD2 therapy | Pre-survey

Managing bone and bone marrow involvement in neuroblastoma with anti-GD2 therapy | Pre-survey

Accredited satellite symposium

This activity is supported by educational funding provided by Y-mAbs Therapeutics, Inc.

Thank you for attending. Please fill out the following survey, and you will be directed to live polling for this event.